July 27 (Reuters) - The U.S. FDA has approved Freenome's (FRNM.O), opens new tab blood-based colorectal cancer screening test for older adults, paving the way for partner ‌Abbott (ABT.N), opens new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results